Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT)

NCT01822951 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: Cerebrolysin
DRUG: Donepezil

Sponsor

Ever Neuro Pharma GmbH